Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials

Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials

Abstract Purpose This study aimed to explore the efficiency and safety of the new generation antibody-drug conjugate Trastuzumab deruxtecan (DS-8201a) in treating HER2-positive solid cancers. Method By searching PubMed, Medline and Ovid for all clinical trials related to the safety and efficacy of D...

Full description

Bibliographic Details
Main Authors: Hanyue Xu, Hao Zhang, Wen Guo, Xi Zhong, Jing Sun, Tao Zhang, Zhoufeng Wang, Xuelei Ma
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Cancer
Subjects:
Trastuzumab deruxtecan (DS-8201a)
Adverse events
Progression free survival
Human epidermal growth factor receptor 2
Breast cancer
Gastric cancer
Online Access:https://doi.org/10.1186/s12885-022-10015-6

Internet

https://doi.org/10.1186/s12885-022-10015-6

Similar Items